サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1450991

等温核酸増幅技術（INAAT）市場レポート：製品、技術、用途、エンドユーザー、地域別、2024-2032

Isothermal Nucleic Acid Amplification Technology Market Report by Product, Technology, Application, End-User, and Region 2024-2032
出版日: | 発行: IMARC | ページ情報: 英文 149 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=158.97円
等温核酸増幅技術（INAAT）市場レポート：製品、技術、用途、エンドユーザー、地域別、2024-2032
出版日: 2024年03月02日
発行: IMARC
ページ情報: 英文 149 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の等温核酸増幅技術（INAAT）市場規模は2023年に31億米ドルに達しました。今後、IMARC Groupは、市場は2032年までに79億米ドルに達し、2024年から2032年の間に10.8％の成長率（CAGR）を示すと予測しています。

等温核酸増幅技術（INAAT）は、分子生物学や組み換えDNA技術において、核酸の検出や同定に用いられます。一定の温度で核酸を増幅するのが一般的で、サーモサイクラー装置が不要になります。主にRNA、DNA、細胞、タンパク質、低分子、イオンに利用され、遺伝性疾患、遺伝性疾患、感染性疾患を迅速、高感度、正確に診断することができます。多用途の核酸ナノ材料の製造に使用されるアンプリコンを生成します。これに加えて、（HIV）、結核、インフルエンザ、A型肝炎、B型肝炎、クラミジア、淋病（CT/NG）など、さまざまな感染症の検出にも役立っています。その結果、INAATは世界中で絶大な支持を得ています。

世界の等温核酸増幅技術（INAAT）市場の動向：

コロナウイルス病（COVID-19）を検出するINAATの開発が進んでいることは、市場にプラスの影響を与えている主な要因の一つです。これに伴い、世界の老年人口の増加、がんやその他の慢性疾患の有病率の上昇、効率的な診断や治療法に対する需要の高まりが、市場の成長に寄与しています。これとは別に、DNAやRNAを増幅するためのループ媒介等温増幅（LAMP）検査の採用や遺伝子組み換え生物（GMO）の同定が、INAATの需要を刺激しています。さらに、鎖置換増幅法（SDA）、シングル・プライマー等温増幅法（SPIA）、組換えポリメラーゼ増幅法（RPA）の開発が、もう一つの成長促進要因として作用しています。さらに、新興国市場をリードする企業による研究開発（R&D）活動への投資の増加が市場を牽引すると予測されています。

本レポートで扱う主な質問

  • 世界の等温核酸増幅技術（INAAT）市場はこれまでどのように推移し、今後数年間はどのように推移するのか？
  • 主要な地域市場は？
  • COVID-19が世界の等温核酸増幅技術（INAAT）市場に与えた影響は？
  • 製品別の市場内訳は？
  • 技術別の市場内訳は？
  • 用途別の市場内訳は？
  • エンドユーザー別の市場内訳は？
  • 業界のバリューチェーンにおける様々な段階とは？
  • 業界の主要な促進要因と課題は何か？
  • 世界の等温核酸増幅技術（INAAT）市場の構造と主要プレーヤーは？
  • 業界の競合の程度は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査目的
  • 利害関係者
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要産業動向

第5章 世界の等温核酸増幅技術（INAAT）市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：製品別

  • 機器
    • 市場動向
    • 市場予測
  • 試薬
    • 市場動向
    • 市場予測

第7章 市場内訳：技術別

  • ヘリカーゼ依存性増幅（HDA）
    • 市場動向
    • 市場予測
  • ニッキング酵素増幅反応（NEAR）
    • 市場動向
    • 市場予測
  • ループ媒介等温増幅法（LAMP）
    • 市場動向
    • 市場予測
  • ストランド置換増幅法（SDA）
    • 市場動向
    • 市場予測
  • 核酸配列に基づく増幅（NASBA）
    • 市場動向
    • 市場予測
  • 転写媒介増幅法（TMA）
    • 市場動向
    • 市場予測
  • シングル・プライマー等温増幅法（SPIA）
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第8章 市場内訳：用途別

  • 感染症診断
    • 市場動向
    • 主要タイプ
      • 肝炎
      • CT/NG
      • HIV
      • インフルエンザ
      • その他
    • 市場予測
  • 血液スクリーニング
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第9章 市場内訳：エンドユーザー別

  • 病院
    • 市場動向
    • 市場予測
  • 診断ラボ
    • 市場動向
    • 市場予測
  • 調査研究所
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第10章 市場内訳：地域別

  • 北米
    • 米国
      • 市場動向
      • 市場予測
    • カナダ
      • 市場動向
      • 市場予測
  • アジア太平洋
    • 中国
      • 市場動向
      • 市場予測
    • 日本
      • 市場動向
      • 市場予測
    • インド
      • 市場動向
      • 市場予測
    • 韓国
      • 市場動向
      • 市場予測
    • オーストラリア
      • 市場動向
      • 市場予測
    • インドネシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 欧州
    • ドイツ
      • 市場動向
      • 市場予測
    • フランス
      • 市場動向
      • 市場予測
    • 英国
      • 市場動向
      • 市場予測
    • イタリア
      • 市場動向
      • 市場予測
    • スペイン
      • 市場動向
      • 市場予測
    • ロシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • ラテンアメリカ
    • ブラジル
      • 市場動向
      • 市場予測
    • メキシコ
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 中東・アフリカ地域
    • 市場動向
    • 市場内訳：国別
    • 市場予測

第11章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第12章 バリューチェーン分析

第13章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第14章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Abbott Laboratories
    • bioMerieux
    • BD（Becton, Dickinson and Company）
    • Eiken Chemical Co. Ltd
    • Hologic Inc.
    • Meridian Bioscience Inc.
    • OptiGene Limited
    • Thermo Fisher Scientific Inc.
    • Tecan Trading AG
    • Ustar Biotechnologies Ltd.
図表

List of Figures

  • Figure 1: Global: Isothermal Nucleic Acid Amplification Technology Market: Major Drivers and Challenges
  • Figure 2: Global: Isothermal Nucleic Acid Amplification Technology Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Isothermal Nucleic Acid Amplification Technology Market: Breakup by Product (in %), 2023
  • Figure 4: Global: Isothermal Nucleic Acid Amplification Technology Market: Breakup by Technology (in %), 2023
  • Figure 5: Global: Isothermal Nucleic Acid Amplification Technology Market: Breakup by Application (in %), 2023
  • Figure 6: Global: Isothermal Nucleic Acid Amplification Technology Market: Breakup by End-User (in %), 2023
  • Figure 7: Global: Isothermal Nucleic Acid Amplification Technology Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Isothermal Nucleic Acid Amplification Technology Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 9: Global: Isothermal Nucleic Acid Amplification Technology (Instruments) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 10: Global: Isothermal Nucleic Acid Amplification Technology (Instruments) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 11: Global: Isothermal Nucleic Acid Amplification Technology (Reagents) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 12: Global: Isothermal Nucleic Acid Amplification Technology (Reagents) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 13: Global: Isothermal Nucleic Acid Amplification Technology (Helicase-Dependent Amplification) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 14: Global: Isothermal Nucleic Acid Amplification Technology (Helicase-Dependent Amplification) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 15: Global: Isothermal Nucleic Acid Amplification Technology (Nicking Enzyme Amplification Reaction) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 16: Global: Isothermal Nucleic Acid Amplification Technology (Nicking Enzyme Amplification Reaction) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 17: Global: Isothermal Nucleic Acid Amplification Technology (Loop-Mediated Isothermal Amplification) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 18: Global: Isothermal Nucleic Acid Amplification Technology (Loop-Mediated Isothermal Amplification) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 19: Global: Isothermal Nucleic Acid Amplification Technology (Strand Displacement Amplification) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 20: Global: Isothermal Nucleic Acid Amplification Technology (Strand Displacement Amplification) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 21: Global: Isothermal Nucleic Acid Amplification Technology (Nucleic Acid Sequence-Based Amplification) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 22: Global: Isothermal Nucleic Acid Amplification Technology (Nucleic Acid Sequence-Based Amplification) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 23: Global: Isothermal Nucleic Acid Amplification Technology (Transcription Mediated Amplification) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 24: Global: Isothermal Nucleic Acid Amplification Technology (Transcription Mediated Amplification) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 25: Global: Isothermal Nucleic Acid Amplification Technology (Single Primer Isothermal Amplification) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 26: Global: Isothermal Nucleic Acid Amplification Technology (Single Primer Isothermal Amplification) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 27: Global: Isothermal Nucleic Acid Amplification Technology (Other Technologies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 28: Global: Isothermal Nucleic Acid Amplification Technology (Other Technologies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 29: Global: Isothermal Nucleic Acid Amplification Technology (Infectious Disease Diagnosis) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 30: Global: Isothermal Nucleic Acid Amplification Technology (Infectious Disease Diagnosis) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 31: Global: Isothermal Nucleic Acid Amplification Technology (Blood Screening) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 32: Global: Isothermal Nucleic Acid Amplification Technology (Blood Screening) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 33: Global: Isothermal Nucleic Acid Amplification Technology (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 34: Global: Isothermal Nucleic Acid Amplification Technology (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 35: Global: Isothermal Nucleic Acid Amplification Technology (Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 36: Global: Isothermal Nucleic Acid Amplification Technology (Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 37: Global: Isothermal Nucleic Acid Amplification Technology (Diagnostic Laboratories) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 38: Global: Isothermal Nucleic Acid Amplification Technology (Diagnostic Laboratories) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 39: Global: Isothermal Nucleic Acid Amplification Technology (Research Laboratories) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 40: Global: Isothermal Nucleic Acid Amplification Technology (Research Laboratories) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 41: Global: Isothermal Nucleic Acid Amplification Technology (Other End-Users) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 42: Global: Isothermal Nucleic Acid Amplification Technology (Other End-Users) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 43: North America: Isothermal Nucleic Acid Amplification Technology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 44: North America: Isothermal Nucleic Acid Amplification Technology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 45: United States: Isothermal Nucleic Acid Amplification Technology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 46: United States: Isothermal Nucleic Acid Amplification Technology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 47: Canada: Isothermal Nucleic Acid Amplification Technology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 48: Canada: Isothermal Nucleic Acid Amplification Technology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 49: Asia Pacific: Isothermal Nucleic Acid Amplification Technology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 50: Asia Pacific: Isothermal Nucleic Acid Amplification Technology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 51: China: Isothermal Nucleic Acid Amplification Technology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 52: China: Isothermal Nucleic Acid Amplification Technology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 53: Japan: Isothermal Nucleic Acid Amplification Technology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 54: Japan: Isothermal Nucleic Acid Amplification Technology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 55: India: Isothermal Nucleic Acid Amplification Technology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 56: India: Isothermal Nucleic Acid Amplification Technology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 57: South Korea: Isothermal Nucleic Acid Amplification Technology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 58: South Korea: Isothermal Nucleic Acid Amplification Technology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 59: Australia: Isothermal Nucleic Acid Amplification Technology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 60: Australia: Isothermal Nucleic Acid Amplification Technology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 61: Indonesia: Isothermal Nucleic Acid Amplification Technology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 62: Indonesia: Isothermal Nucleic Acid Amplification Technology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 63: Others: Isothermal Nucleic Acid Amplification Technology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 64: Others: Isothermal Nucleic Acid Amplification Technology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 65: Europe: Isothermal Nucleic Acid Amplification Technology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 66: Europe: Isothermal Nucleic Acid Amplification Technology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 67: Germany: Isothermal Nucleic Acid Amplification Technology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 68: Germany: Isothermal Nucleic Acid Amplification Technology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 69: France: Isothermal Nucleic Acid Amplification Technology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 70: France: Isothermal Nucleic Acid Amplification Technology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 71: United Kingdom: Isothermal Nucleic Acid Amplification Technology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 72: United Kingdom: Isothermal Nucleic Acid Amplification Technology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 73: Italy: Isothermal Nucleic Acid Amplification Technology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 74: Italy: Isothermal Nucleic Acid Amplification Technology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 75: Spain: Isothermal Nucleic Acid Amplification Technology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 76: Spain: Isothermal Nucleic Acid Amplification Technology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 77: Russia: Isothermal Nucleic Acid Amplification Technology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 78: Russia: Isothermal Nucleic Acid Amplification Technology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 79: Others: Isothermal Nucleic Acid Amplification Technology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 80: Others: Isothermal Nucleic Acid Amplification Technology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 81: Latin America: Isothermal Nucleic Acid Amplification Technology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 82: Latin America: Isothermal Nucleic Acid Amplification Technology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 83: Brazil: Isothermal Nucleic Acid Amplification Technology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 84: Brazil: Isothermal Nucleic Acid Amplification Technology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 85: Mexico: Isothermal Nucleic Acid Amplification Technology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 86: Mexico: Isothermal Nucleic Acid Amplification Technology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 87: Others: Isothermal Nucleic Acid Amplification Technology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 88: Others: Isothermal Nucleic Acid Amplification Technology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 89: Middle East and Africa: Isothermal Nucleic Acid Amplification Technology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 90: Middle East and Africa: Isothermal Nucleic Acid Amplification Technology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 91: Global: Isothermal Nucleic Acid Amplification Technology Industry: SWOT Analysis
  • Figure 92: Global: Isothermal Nucleic Acid Amplification Technology Industry: Value Chain Analysis
  • Figure 93: Global: Isothermal Nucleic Acid Amplification Technology Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Isothermal Nucleic Acid Amplification Technology Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Isothermal Nucleic Acid Amplification Technology Market Forecast: Breakup by Product (in Million US$), 2024-2032
  • Table 3: Global: Isothermal Nucleic Acid Amplification Technology Market Forecast: Breakup by Technology (in Million US$), 2024-2032
  • Table 4: Global: Isothermal Nucleic Acid Amplification Technology Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 5: Global: Isothermal Nucleic Acid Amplification Technology Market Forecast: Breakup by End-User (in Million US$), 2024-2032
  • Table 6: Global: Isothermal Nucleic Acid Amplification Technology Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 7: Global: Isothermal Nucleic Acid Amplification Technology Market: Competitive Structure
  • Table 8: Global: Isothermal Nucleic Acid Amplification Technology Market: Key Players
目次
Product Code: SR112024A2205

The global isothermal nucleic acid amplification technology (INAAT) market size reached US$ 3.1 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 7.9 Billion by 2032, exhibiting a growth rate (CAGR) of 10.8% during 2024-2032.

The isothermal nucleic acid amplification technology (INAAT) is used in molecular biology and recombinant DNA technologies for detecting and identifying nucleic acids. It is commonly used to amplify nucleic acids at a constant temperature, thereby eliminating the need for thermocycler equipment. It is majorly utilized for RNA, DNA, cells, proteins, small molecules, and ions to ensure the rapid, sensitive and accurate diagnosis of genetic, inherited, and infectious diseases. It generates amplicons that are employed in producing versatile nucleic acid nanomaterials. Besides this, it assists in detecting various infectious diseases, such as (HIV), tuberculosis, influenza, hepatitis A and B, chlamydia, and gonorrhea (CT/NG). As a result, INAAT is gaining immense traction across the globe.

Global Isothermal Nucleic Acid Amplification Technology Market Trends:

The ongoing development in INAAT for detecting coronavirus disease (COVID-19) represents one of the key factors positively influencing the market. In line with this, the increasing geriatric population globally and the rising prevalence of cancer and other chronic medical disorders, along with the escalating demand for efficient diagnosis and treatment alternatives, are contributing to the market growth. Apart from this, the adoption of loop-mediated isothermal amplification (LAMP) tests to amplify DNA and RNA and the identification of genetically modified organisms (GMOs) is catalyzing the demand for INAAT. Furthermore, the development of strand displacement amplification (SDA), single primer isothermal amplification (SPIA), and recombinase polymerase amplification (RPA) are acting as another growth-inducing factor. Moreover, increasing investments in research and development (R&D) activities by leading market players are projected to drive the market.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global isothermal nucleic acid amplification technology market report, along with forecasts at the global, regional, and country level from 2024-2032. Our report has categorized the market based on product, technology, application, and end-user.

Breakup by Product:

Instruments

Reagents

Reagents hold the majority of the global isothermal nucleic acid amplification technology market share due to their increasing use in therapeutics.

Breakup by Technology:

Helicase-Dependent Amplification (HDA)

Nicking Enzyme Amplification Reaction (NEAR)

Loop-Mediated Isothermal Amplification (LAMP)

Strand Displacement Amplification (SDA)

Nucleic Acid Sequence-Based Amplification (NASBA)

Transcription Mediated Amplification (TMA)

Single Primer Isothermal Amplification (SPIA)

Others

TMA accounts for the majority of the total market share as it allows a clinical laboratory to perform nucleic acid test (NAT) assays for blood screening with fewer steps and less processing time.

Breakup by Application:

Infectious Disease Diagnosis

Hepatitis

CT/NG

HIV

Influenza

Others

Blood Screening

Others

Infectious disease diagnosis currently dominates the market due to the rising prevalence of infectious diseases across the globe.

Breakup by End-User:

Hospitals

Diagnostic Laboratories

Research Laboratories

Others

Hospitals presently dominate the market due to the increasing number of hospitals and significant development in the healthcare industry.

Breakup by Region:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America exhibits a clear dominance in the market due to the shifting consumer preference for INAAT testing over traditional diagnostic procedures.

Competitive Landscape:

The competitive landscape of the market has been analyzed in the report, along with the detailed profiles of the major players operating in the industry. Some of these players are Abbott Laboratories, bioMerieux SA, Becton, Dickinson and Company, Eiken Chemical Co. Ltd., Hologic Inc., Meridian Bioscience Inc., OptiGene Limited, Thermo Fisher Scientific Inc., Tecan Trading AG, and Ustar Biotechnologies Ltd.

Key Questions Answered in This Report:

  • How has the global isothermal nucleic acid amplification technology market performed so far and how will it perform in the coming years?
  • What are the key regional markets?
  • What has been the impact of COVID-19 on the global isothermal nucleic acid amplification technology market?
  • What is the breakup of the market based on the product?
  • What is the breakup of the market based on the technology?
  • What is the breakup of the market based on the application?
  • What is the breakup of the market based on the end-user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global isothermal nucleic acid amplification technology market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Isothermal Nucleic Acid Amplification Technology Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of Covid-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Instruments
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Reagents
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Technology

  • 7.1 Helicase-Dependent Amplification (HDA)
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Nicking Enzyme Amplification Reaction (NEAR)
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Loop-Mediated Isothermal Amplification (LAMP)
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Strand Displacement Amplification (SDA)
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Nucleic Acid Sequence-Based Amplification (NASBA)
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Transcription Mediated Amplification (TMA)
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast
  • 7.7 Single Primer Isothermal Amplification (SPIA)
    • 7.7.1 Market Trends
    • 7.7.2 Market Forecast
  • 7.8 Others
    • 7.8.1 Market Trends
    • 7.8.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Infectious Disease Diagnosis
    • 8.1.1 Market Trends
    • 8.1.2 Major Types
      • 8.1.2.1 Hepatitis
      • 8.1.2.2 CT/NG
      • 8.1.2.3 HIV
      • 8.1.2.4 Influenza
      • 8.1.2.5 Others
    • 8.1.3 Market Forecast
  • 8.2 Blood Screening
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Others
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by End-User

  • 9.1 Hospitals
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Diagnostic Laboratories
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Research Laboratories
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Others
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Abbott Laboratories
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 bioMerieux
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 BD (Becton, Dickinson and Company)
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Eiken Chemical Co. Ltd
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
    • 14.3.5 Hologic Inc.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Meridian Bioscience Inc.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 OptiGene Limited
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
    • 14.3.8 Thermo Fisher Scientific Inc.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Tecan Trading AG
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
    • 14.3.10 Ustar Biotechnologies Ltd.
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio